Tarsus Pharmaceuticals (TARS)
(Delayed Data from NSDQ)
$27.11 USD
-0.49 (-1.78%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $27.09 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Earnings News For TARS
-
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
-
Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
-
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
-
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
-
Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
-
Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements
-
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Misses Revenue Estimates
-
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Misses Revenue Estimates
-
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Misses Revenue Estimates
-
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release